EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Siraitia grosvenorii Residual Extract Inhibits Inflammation in RAW264.7 Macrophages and Attenuates Osteoarthritis Progression in a Rat Model

Yun Mi Lee, Misun Kim, Heung Joo Yuk iD, Seung-Hyung Kim, Dong-Seon Kim iD

Nutrients · 2023

DOI: 10.3390/nu15061417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Yun Mi Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Dinoprostone. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Institute of Oriental Medicine, INNOPOLIS Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA) is a degenerative joint disease characterised by cartilage degeneration and chondrocyte inflammation. We investigated the anti-inflammatory effects of the Siraitia grosvenorii residual extract (SGRE) in lipopolysaccharide (LPS)-induced RAW264.7 macrophages in vitro and its anti-osteoarthritic effects in a monosodium iodoacetate (MIA)-induced OA rat model. SGRE dose-dependently decreased nitric oxide (NO) production in LPS-induced RAW264.7 cells. Moreover, SGRE reduced the pro-inflammatory mediator (cyclooxygenase-2 (COX2), inducible NO synthase (iNOS), and prostaglandin E2 (PGE2)) and pro-inflammatory cytokine (interleukin-(IL)-1β, IL-6, and tumour necrosis factor (TNF-α)) levels. SGRE suppressed nuclear factor kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) pathway activation in RAW264.7 macrophages, thus reducing inflammation. Rats were orally administered SGRE (150 or 200 mg/kg) or the positive control drug JOINS (20 mg/kg) 3 days before MIA injection, and once daily for 21 days thereafter. SGRE elevated the hind paw weight-bearing distribution, thus relieving pain. It also reduced inflammation by inhibiting inflammatory mediator (iNOS, COX-2, 5-LOX, PGE2, and LTB4) and cytokine (IL-1β, IL-6, and TNF-α) expression, downregulating cartilage-degrading enzymes, such as MMP-1, -2, -9, and -13. SGRE significantly reduced the SOX9 and extracellular matrix component (ACAN and COL2A1) levels. Therefore, SGRE is a potential therapeutic active agent against inflammation and OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaDinoprostoneRatsAnimalsLipopolysaccharidesInterleukin-6InflammationNF-kappa BCytokinesMacrophagesNitric OxideNitric Oxide Synthase Type IICyclooxygenase 2

Stichwörter der Autor:innen

Siraitia grosvenorii residual extractextracellular matrix (ECM)inflammationosteoarthritis

Substanzen

Tumor Necrosis Factor-alphaDinoprostoneLipopolysaccharidesInterleukin-6NF-kappa BCytokinesNitric OxideNitric Oxide Synthase Type IICyclooxygenase 2

Autor:innen und Institutionen

  • KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
  • Institute of Traditional Medicine and Bioscience, Daejeon University, Daejeon 34520, Republic of Korea.

ORCID-Profile: Heung Joo Yuk, Dong-Seon Kim

Förderung

  • Korea Institute of Oriental Medicine
  • INNOPOLIS Foundation of Korea

Zitieren

APA

Lee, Y. M., Kim, M., Yuk, H. J., Kim, S. H., & Kim, D. S. (2023). Siraitia grosvenorii Residual Extract Inhibits Inflammation in RAW264.7 Macrophages and Attenuates Osteoarthritis Progression in a Rat Model. Nutrients. https://doi.org/10.3390/nu15061417

Vancouver

Lee YM, Kim M, Yuk HJ, Kim SH, Kim DS. Siraitia grosvenorii Residual Extract Inhibits Inflammation in RAW264.7 Macrophages and Attenuates Osteoarthritis Progression in a Rat Model. Nutrients. 2023. doi:10.3390/nu15061417

BibTeX
@article{Lee2023,
  author = {Lee, Yun Mi and Kim, Misun and Yuk, Heung Joo and Kim, Seung-Hyung and Kim, Dong-Seon},
  title = {Siraitia grosvenorii Residual Extract Inhibits Inflammation in RAW264.7 Macrophages and Attenuates Osteoarthritis Progression in a Rat Model},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15061417}
}
Kostenlos starten →